Keyphrases
Graft-versus-host Disease (GvHD)
100%
Life-threatening
100%
Human Chorionic Gonadotropin
100%
Open-label Clinical Trial
100%
Epidermal Growth Factor
100%
Amphiregulin
37%
Non-responders
25%
Disease Therapy
25%
Every Other Day
25%
Minnesota
12%
Improved Outcomes
12%
Immunosuppression
12%
Twice Daily
12%
CD8+ T Cells
12%
Phase II Clinical Trial
12%
High Risk
12%
Standard of Care
12%
Lower Gastrointestinal Tract
12%
Physician Choice
12%
T Cell Subsets
12%
Supportive Care
12%
Commercially Available
12%
Cell-to-cell
12%
Immune Tolerance
12%
Plasmablast
12%
Peripheral Blood
12%
Response to Therapy
12%
Severe Acute
12%
Maintenance Dose
12%
Peripheral Blood T Cells
12%
Complete Response
12%
Partial Response
12%
Methylprednisolone
12%
High-dose Corticosteroids
12%
Inflammation Resolution
12%
KLRG1
12%
Immune Parameters
12%
Epithelial Repair
12%
Organon
12%
Prospective Phase II Study
12%
Tim-3
12%
Mass Cytometry
12%
Jersey City
12%
CARE Measure
12%
Medicine and Dentistry
Clinical Trial
100%
Urinary System
100%
Acute Graft Versus Host Disease
100%
Chorionic Gonadotropin
100%
Epidermal Growth Factor
100%
Amphiregulin
37%
Combination Therapy
25%
T Cell
12%
Drug Megadose
12%
Immunological Tolerance
12%
Immunosuppressive Treatment
12%
Immunocompetent Cell
12%
Lower Digestive Tract
12%
Supportive Care
12%
Maintenance Drug Dose
12%
T Cell Subset
12%
Plasmablast
12%
CD8 Antigen
12%
Mass Cytometry
12%
Graft Versus Host Reaction
12%
Methylprednisolone
12%
Immunosuppressant
12%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Acute Graft Versus Host Disease
100%
Chorionic Gonadotropin
100%
Epidermal Growth Factor
100%
Amphiregulin
37%
Combination Therapy
25%
Graft Versus Host Reaction
12%
Maintenance Dose
12%
CD8 Antigen
12%
Immunosuppressive Agent
12%
Inflammation
12%
Methylprednisolone
12%
Immunology and Microbiology
Acute Graft Versus Host Disease
100%
Epidermal Growth Factor
100%
Amphiregulin
37%
Blood Plasma
25%
Graft-Versus-Host Disease
12%
Immune Tolerance
12%
Immunosuppression
12%
T Cell Subset
12%
Mass Cytometry
12%
Lower Gastrointestinal Tract
12%
Immunocompetent Cell
12%
Drug Megadose
12%
CD8
12%
Plasmablast
12%
Methylprednisolone
12%
Maintenance Drug Dose
12%
T Cell
12%